Schizophrenia and the risk of cardiovascular diseases: A meta-analysis of thirteen cohort studies

Journal of Psychiatric Research

Volumn 47, Issue 11, 2013, Pages 1549-1556

  Fan, Zuoxu ^a   Wu, Yaoyao ^b   Shen, Jian ^a   Ji, Tao ^a   Zhan, Renya ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b People's Liberation Army 117 Hospital   (China)

Author keywords

Cardiovascular disease; Cohort studies; Meta analysis; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASE; COHORT STUDIES; META-ANALYSIS; SCHIZOPHRENIA;

CARDIOVASCULAR DISEASES; COHORT STUDIES; DATABASES, FACTUAL; HUMANS; INCIDENCE; SCHIZOPHRENIA;

EID: 84884414612     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.07.011     Document Type: Article

References (40)

1. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
2. Bresee L.C., Majumdar S.R., Patten S.B., Johnson J.A. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophrenia Research 2010, 117:75-82.
3. Brown S., Inskip H., Barraclough B. Causes of the excess mortality of schizophrenia. British Journal of Psychiatry 2000, 177:212-217.
4. Brown S., Kim M., Mitchell C., Inskip H. Twenty-five year mortality of a community cohort with Schizophrenia. British Journal of Psychiatry 2010, 196:116-121.
5. Callaghan R.C., Boire M.D., Lazo R.G., McKenzie K., Cohn T. Schizophrenia and the incidence of cardiovascular morbidity: a population-based longitudinal study in Ontario, Canada. Schizophrenia Research 2009, 115:325-332.
6. Capasso R.M., Lineberry T.W., Bostwick J.M., Decker P.A., St Sauver J. Mortality in schizophrenia and schizoaffective disorder: an Olmsted county, Minnesota cohort: 1950-2005. Schizophrenia Research 2008, 98:287-294.
7. Carney C.P., Jones L., Woolson R.F. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. Journal of General Internal Medicine 2006, 21:1133-1137.
8. Chuang H.T., Mansell C., Patten S.B. Lifestyle characteristics of psychiatric outpatients. Canadian Journal of Psychiatry 2008, 53:260-266.
9. Curkendall S.M., Mo J., Glasser D.B., Rose Stang M., Jones J.K. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. Journal of Clinical Psychiatry 2004, 65:715-720.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188.
11. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
12. Enger C., Weatherby L., Reynolds R.F., Glasser D.B., Walker A.M. Serious cardiovascular events and mortality among patients with schizophrenia. Journal of Nervous and Mental Disease 2004, 192:19-27.
13. Filik R., Sipos A., Kehoe P.G., Burns T., Cooper S.J., Stevens H., et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatrica Scandinavica 2006, 113:298-305.
14. Freedman R. Schizophrenia. New England Journal of Medicine 2003, 349:1738-1749.
15. Harris E.C., Barraclough B. Excess mortality of mental disorder. British Journal of Psychiatry 1998, 173:11-53.
16. Hennekens C.H., Hennekens A.R., Hollar D., Casey D.E. Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 2005, 150:1115-1121.
17. Jakobsen A.H., Foldager L., Parker G., Munk-Jørgensen P. Quantifying links between acute myocardial infarction and depression, anxiety and schizophrenia using case register databases. Journal of Affective Disorders 2008, 109:177-181.
18. Kavanagh D.J., McGrath J., Saunders J.B., Dore G., Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 2002, 62:743-755.
19. Kelly D.L., McMahon R.P., Wehring H.J., Liu F., Mackowick K.M., Boggs D.L., et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin 2011, 37:832-838.
20. Lahti M., Tiihonen J., Wildgust H., Beary M., Hodgson R., Kajantie E., et al. Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychological Medicine 2012, 12:1-11.
21. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Annals of Internal Medicine 1997, 1279:820-826.
22. Laursen T.M. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophrenia Research 2011, 131:101-104.
23. Laursen T.M., Munk-Olsen T., Nordentoft M., Mortensen P.B. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. Journal of Clinical Psychiatry 2007, 68:899-907.
24. Leucht S., Burkard T., Henderson J., Maj M., Sartorius N. Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica 2007, 116:317-333.
25. Liao C.H., Chang C.S., Wei W.C., Chang S.N., Liao C.C., Lane H.Y., et al. Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study. Schizophrenia Research 2011, 126:110-116.
26. Lin H.C., Chen Y.H., Lee H.C., Lin H.C. Increased risk of acute myocardial infarction after acute episode of schizophrenia: 6 year follow-up study. Australian and New Zealand Journal of Psychiatry 2010, 44:273-279.
27. Lin H.C., Hsiao F.H., Pfeiffer S., Hwang Y.T., Lee H.C. An increased risk of stroke among young schizophrenia patients. Schizophrenia Research 2008, 101:234-241.
28. Mackin P. Cardiac side effects of psychiatric drugs. Human Psychopharmacology: Clinical and Experimental 2008, 23:3-14.
29. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959, 22:719-748.
30. McCreadie R.G., Scottish Schizophrenia Lifestyle Group Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. British Journal of Psychiatry 2003, 183:534-539.
31. McDermott S., Moran R., Platt T., Isaac T., Wood H., Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Mental Health Journal 2005, 41:747-755.
32. Mitchell A.J., Lawrence D. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. The British Journal of Psychiatry 2011, 198:434-441.
33. Muck-Jørgensen P., Mors O., Mortensen P.B., Ewald H. The schizophrenic patient in the somatic hospital. Acta Psychiatrica Scandinavica Supplement 2000, 96-99.
34. Newcomer J.W., Haupt D.W., Fucetola R., Melson A.K., Schweiger J.A., Cooper B.P., et al. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Archives of General Psychiatry 2002, 59:337-345.
35. Osby U., Correia N., Brandt L., Ekbom A., Sparén P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research 2000, 45:21-28.
36. Sacchetti E., Turrina C., Valsecchi P. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review. Drug Safety 2010, 33:273-288.
37. Saha S., Chant D., McGrath J. Asystematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007, 64:1123-1131.
38. Shen H.N., Lu C.L., Yang H.H. Increased risks of acute organ dysfunction and mortality in intensive care unit patients with schizophrenia: a nationwide population-based study. Psychosomatic Medicine 2011, 73:620-626.
39. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. Journal of the American Medical Association 2000, 283:2008-2012.
40. Tsai K.Y., Lee C.C., Chou Y.M., Su C.Y., Chou F.H. The incidence and relative risk of stroke in patients with schizophrenia: a five-year follow-up study. Schizophrenia Research 2012, 138:41-47.